期刊文献+

蛋白质组学在大肠癌研究中的应用 被引量:2

Application of proteomics in colorectal cancer research
下载PDF
导出
摘要 大肠癌是我国常见恶性肿瘤之一,且发病率和死亡率呈逐年上升趋势.蛋白质组学的出现,使大肠癌的研究有了进一步的发展.本文就国内外蛋白质组学在大肠癌诊断、发病机制、治疗等方面的研究进行综述. Colorectal cancer is one of the most common malignant tumors in China. Its morbidity and mortality are increasing year by year. The emergence of proteomics has pushed colorectal cancer research forward. In this article, we will review the application of proteomics in the study of the diagnosis, pathogenesis and treatment of colorectal cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第33期3431-3436,共6页 World Chinese Journal of Digestology
关键词 蛋白质组学 大肠癌 标志物 发病机制 治疗 蛋白文库 Proteomics Colorectal cancer Mark-ers Pathogenesis Therapy Protein library
  • 相关文献

参考文献28

  • 1Witzmann F, Clack J, Fultz C, Jarnot B. Twodimensional electrophoretic mapping of hepatic and renal stress proteins. Electrophoresis 1995; 16: 451-459.
  • 2Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom 2001; 36:1083-1091.
  • 3陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2005,1469-1471.
  • 4Roessler M, Rollinger W, Palme S, Hagmann ML, Berndt P, Engel AM, Schneidinger B, Pfeffer M, Andres H, Karl J, Bodenmuller H, Ruschoff J, Henkel T, Rohr G, Rossol S, Rosch W, Langen H, Zolg W, Tacke M. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin Cancer Res 2005; 11:6550-6557.
  • 5Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmuller H, Ruschoff J, Henkel T, Rohr G, Rossol S, Rosch W, Langen H, Zolg W, Tacke M. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometrybased approach for data analysis. Mol Cell Proteomics 2006; 5:2092-2101.
  • 6Wu CC, Chen HC, Chen SJ, Liu HP, Hsieh YY, Yu CJ, Tang R, Hsieh LL, Yu JS, Chang YS. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008; 8:316-332.
  • 7Kim HJ, Kang HJ, Lee H, Lee ST, Yu MH, Kim H, Lee C. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 2009; 8:1368-1379.
  • 8Ma Y, Peng J, Liu W, Zhang P, Huang L, Gao B, Shen T, Zhou Y, Chen H, Chu Z, Zhang M, Qin H. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics 2009; 8: 1878-1890.
  • 9Alfonso P, Nunez A, Madoz-Gurpide J, Lombardia L, Sanchez L, Casal JI, Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005; 5: 2602-2611.
  • 10Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 2006; 6: 3466-3476.

共引文献168

同被引文献39

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部